Opportunities and challenges of hepatocellular carcinoma organoids for targeted drugs sensitivity screening

Abstract

Hepatocellular carcinoma is one of the malignancies worldwide with a high mortality rate and an increasing incidence. Molecular Targeted agents are its common first-line treatment. Organoid technology, as a cutting-edge technology, is gradually being applied in the development of therapeutic oncology. Organoid models can be used to perform sensitivity screening of targeted drugs to facilitate the development of innovative therapeutic agents for the treatment of hepatocellular carcinoma. The purpose of this review is to provide an overview of the opportunities and challenges of hepatocellular carcinoma organoids in targeted drug sensitivity testing as well as a future outlook.

Advances in Ferroptosis-Inducing Agents by Targeted Delivery System in Cancer Therapy

“… 1 However, due to the inherent limitations of conventional treatment approaches and the heterogeneity of tumors, their clinical efficacy remains dismal. 2 , 3 Although immunotherapy has become a promising cancer treatment in recent years, its narrow anti-tumor spectrum, potential toxicity, and autoimmune suppression have greatly limited its clinical application. 4 , 5 Additionally, drug delivery barriers within solid tumors account for the poor efficacy of tumor immunotherapy.…”

pH-Activatable Charge-Reversal Polymer-Based Nanocarriers for Targeted Delivery of Antihepatoma Compound

“…Hepatocellular carcinoma is the third most common cause of cancer-related deaths worldwide, with high incidence and low survival, and represents a major global healthcare challenge. , Chemotherapy, as one of the mainstream treatments, has been widely applied to clinical cancer treatment . Celastrol (CSL) is a natural pentacyclic triterpenoid extracted from the root bark of Tripterygium glycosides and has exhibited many pharmacological effects, such as anti-oxidant, anti-autoimmune, anti-inflammatory, and neuroprotective , Notably, CSL, as a Chinese herbal medicine, has shown excellent antitumor activity in various types of tumor cells, which can inhibit proteasome activity and exhibit the potential to induce cancer cell apoptosis.…”